METME-PG2 TABLETS

Price 142.00 INR/ Strip

Get a Price/Quote

MOQ : 500 Strips

METME-PG2 TABLETS Specification

Molecular Formula
Metformin: C4H11N5; Pioglitazone: C19H20N2O3S

Dosage Guidelines
As directed by the physician

HS Code
30049099

Assay
Each tablet contains Metformin Hydrochloride IP 500 mg + Pioglitazone Hydrochloride IP 15 mg

CAS No
1115-70-4 (Metformin); 110011-63-9 (Pioglitazone)

Suitable For
Adults

Refractive Rate
N/A (solid tablets)

Pacakaging (Quantity Per Box)
10 x 15 Tablets

Appearance
White to off-white tablets

Purity
>98%

Melting Point
Metformin: 223-226C; Pioglitazone: 193C

Acid Value
Not applicable for this formulation

Physical Form
Tablets

Solubility
Metformin: Freely soluble in water; Pioglitazone: Insoluble in water

Type
Pharmaceutical Tablets

Ingredients
Metformin Hydrochloride, Pioglitazone Hydrochloride, Excipients

Feature
Combination anti-diabetic medication

Shelf Life
24 months from manufacture

Storage Instructions
Store in a cool, dry place; Protect from light

About METME-PG2 TABLETS

Clearance Alert! METME-PG2 TABLETS-your last chance to acquire renowned diabetes management at a ravishing reduced price. Combining top-drawer Metformin and Pioglitazone, this white, standard-size tablet is expertly formulated to help control blood glucose in adults with Type 2 Diabetes Mellitus. Exclusively for prescription use, METME-PG2 offers a trusted, combination anti-diabetic solution. Sheltered securely in robust packaging (10 x 15 tablets), each tablet is assayed at clinical-grade purity for optimal efficacy. Not suitable for children or pregnant women without medical guidance. Store in a cool, dry place and protect from light.

Targeted Application and Effective Usage

METME-PG2 TABLETS are engineered for oral use, specifically recommended for adults diagnosed with Type 2 Diabetes Mellitus. The combination formula is suitable for daily management of glycemic levels, and should be administered strictly as directed by your physician. For optimal results, METME-PG2 is designed with high bioavailability, making it ideal for those seeking reliable, continuous diabetes control. This product is intended solely for medical use; consult your healthcare provider before starting therapy.

Swift Arrival and Exclusive Sample Policy

Benefit from rapid delivery offers for METME-PG2 TABLETS, ensuring timely arrival to all major domestic markets across India. Sample policy allows for limited valuation samples based on distributor agreements. Experience prompt order fulfillment whether you are a wholesaler, exporter, or trader. Delivery times are optimized for efficiency; please check with your supplier for specific lead times. METME-PG2 is available for bulk purchase with secure packaging guaranteed for all shipments.

FAQ's of METME-PG2 TABLETS:

Q: How should METME-PG2 TABLETS be used for best results?

A: METME-PG2 TABLETS must be taken orally, exactly as directed by your physician. Dosage and duration depend on individual health status, ensuring optimal control of blood sugar levels in Type 2 Diabetes Mellitus.

Q: What are the main ingredients in METME-PG2 TABLETS?

A: Each METME-PG2 TABLET contains Metformin Hydrochloride IP 500 mg and Pioglitazone Hydrochloride IP 15 mg, complemented by pharmaceutical excipients for stability and efficacy.

Q: When is METME-PG2 TABLETS not recommended?

A: METME-PG2 is not recommended for children, pregnant women, or lactating mothers unless explicitly advised by a qualified healthcare professional.

Q: Where is METME-PG2 TABLETS distributed and supplied?

A: METME-PG2 TABLETS are widely distributed and supplied across India, catering to domestic pharmacies, wholesalers, hospitals, and authorized medical outlets.

Q: What is the delivery process for METME-PG2 TABLETS?

A: Upon order confirmation, METME-PG2 TABLETS are securely packaged and dispatched for swift delivery, with arrival times dependent on your location and supplier policies.

Q: How does METME-PG2 TABLETS benefit adults with Type 2 Diabetes Mellitus?

A: METME-PG2 TABLETS offer superior glycemic management through the synergistic action of Metformin and Pioglitazone, aiding in improved blood sugar regulation and long-term diabetes control.

Tell us about your requirement